Biotech industry.
FY13 appropriations bills, including issues related to FDA funding and drug approval/review oversight process. Monitored legislation related to altering sequestration targets.  Issues related to comprehensive tax reform, tax treatment of foreign-owned U.S. corporations, and tax extenders, including R & D tax credit.   S.3521, Family and Business Tax Cut Certainty Act of 2012 (tax "extenders").  Corporate tax reform issues.  Monitored fiscal clif legislation - American Taxpayer Releif Act (H.R.8).
BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
SQUIRE PATTON BOGGS
2550 M STREET, NW, WASHINGTON, DC, 20037, US
MANNY ROSSMAN (Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09) KEVIN O'NEILL
Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09